Companies researching REVLIMID (lenalidomide)
Lenalidomide, marketed as REVLIMID, is a drug used to treat conditions such as myelodysplastic syndrome, multiple myeloma, and mantle cell lymphoma.
9
companies
List of companies that research REVLIMID (lenalidomide)
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
United States | Pharmaceutical Manufacturing | 39k | $46B | REVLIMID (lenalidomide) | |
United States | Hospitals and Health Care | 12k | $2.4B | REVLIMID (lenalidomide) | |
Canada | Hospitals and Health Care | 5k | REVLIMID (lenalidomide) | ||
United States | Business Consulting and Services | 20k | $2.9B | REVLIMID (lenalidomide) | |
Czech Republic | Pharmaceutical Manufacturing | 4.7k | $528M | REVLIMID (lenalidomide) |
Showing top companies out of 9 that research REVLIMID (lenalidomide). Get the full list on TheirStack.
Frequently asked questions




